Case Description:
A male patient aged approximately 38–40 years, presented with typhoid fever. He had been under treatment for nearly one month at a government hospital in Lucknow, India, without significant improvement. The attending allopathic physicians eventually advised referral to Gwalior for further management.
The patient’s elder son, a close acquaintance of mine, described the clinical picture in detail. Based on the symptomatology provided, I prescribed Bryonia 30, four doses at hourly intervals.
The patient experienced high fever throughout the night but awoke the following morning with noticeable relief. Over the course of the day, his condition steadily improved, and within eight days he had regained complete health.
Symptomatology:
The patient exhibited the following characteristic symptoms:
1. Severe headache and chest pain, markedly aggravated by the slightest movement.
2. Complete loss of appetite.
3. Constipation.
4. A strong desire to remain lying quietly and undisturbed.
5. Inability to rise from bed without supporting the forehead with his hand
Discussion:
Bryonia is frequently indicated in febrile conditions where inflammatory states dominate, especially when restlessness or motion exacerbates symptoms. In this case, the cephalic and thoracic pains, coupled with the patient’s aversion to movement and desire for quiet repose, strongly pointed toward Bryonia.
The rapid improvement following administration highlights the clinical efficacy of symptom‑based prescription in homeopathic practice. Notably, the patient’s recovery within eight days contrasts with the prolonged ineffective treatment under conventional management.
Conclusion:
This case demonstrates the successful application of Bryonia 30 in typhoid fever, guided by the hallmark modality of aggravation from motion. Four doses administered at hourly intervals-initiated recovery, with complete restoration of health achieved in approximately eight days.
Such cases underscore the importance of individualized remedy selection in homeopathy, reaffirming the therapeutic potential of Bryonia in acute febrile disorders.
